ArticleMolecular therapy. Methods & clinical development2025

Therapeutic mRNA delivery of CRISPR-Cas9 to the trabecular meshwork reverses ocular hypertension in myocilin glaucoma.

Sam Yacoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.